Ftse Mib
35.355,87
0,58%
DAX
18.869,36
0,78%
S&P 500
5.308,15
1,17%
NASDAQ
16.736,22
1,36%
Bitcoin
65.909,17
7,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kindred Biosciences Inc (KIN) Kindred Biosciences Inc (KIN) Notizie

KIN

Kindred Biosciences (KIN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KIN
DataOraFonteTitoloSimboloCompagnia
14/02/202223:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KINKindred Biosciences Inc
02/09/202112:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KINKindred Biosciences Inc
31/08/202100:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KINKindred Biosciences Inc
30/08/202115:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KINKindred Biosciences Inc
30/08/202115:09Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:KINKindred Biosciences Inc
30/08/202115:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KINKindred Biosciences Inc
30/08/202115:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KINKindred Biosciences Inc
27/08/202123:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:KINKindred Biosciences Inc
10/08/202112:01Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:KINKindred Biosciences Inc
05/08/202122:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KINKindred Biosciences Inc
21/07/202115:11Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:KINKindred Biosciences Inc
09/07/202123:31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:KINKindred Biosciences Inc
25/06/202122:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KINKindred Biosciences Inc
25/06/202122:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:KINKindred Biosciences Inc
17/06/202100:45PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc.NASDAQ:KINKindred Biosciences Inc
16/06/202113:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KINKindred Biosciences Inc
16/06/202112:30Business WireElanco Announces Agreement to Acquire Kindred BiosciencesNASDAQ:KINKindred Biosciences Inc
02/06/202114:31PR Newswire (US)Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Preventi...NASDAQ:KINKindred Biosciences Inc
25/05/202114:42PR Newswire (US)Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XINASDAQ:KINKindred Biosciences Inc
11/05/202122:03PR Newswire (US)Kindred Biosciences Announces First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
03/05/202114:42PR Newswire (US)Kindred Biosciences to Announce First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
29/04/202122:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KINKindred Biosciences Inc
28/04/202114:32PR Newswire (US)Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationNASDAQ:KINKindred Biosciences Inc
20/04/202122:03PR Newswire (US)Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyNASDAQ:KINKindred Biosciences Inc
01/04/202123:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KINKindred Biosciences Inc
16/03/202121:02PR Newswire (US)Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
08/03/202114:32PR Newswire (US)Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
02/03/202114:31PR Newswire (US)Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences ConferenceNASDAQ:KINKindred Biosciences Inc
25/02/202114:01PR Newswire (US)Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic IndicationNASDAQ:KINKindred Biosciences Inc
16/02/202122:02PR Newswire (US)Kindred Biosciences to Present at the BofA Securities Animal Health Virtual SummitNASDAQ:KINKindred Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KIN

La tua Cronologia

HUOB
ELFBTC
Aelf
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network